Drug
Clobetasol
Clobetasol: highest development phase Post-Market, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| clobetasol NCT00779792 | Post-Market | Dermatitis, Contact |
Latest
No recent events.
Follow Clobetasol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.